×

[SCI] (The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients)

[SCI] (Werniche’s encephalopathy following allogeneic hematopoietic stem cell transplantation)

[SCI] (Small bowel carcinoma in young patient detected by double-balloon enteroscopy)

[SCI] (The role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma)

[SCI] (Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study)

[SCI] (Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR)

[SCI] (The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer)

[SCI] (A case report of primary pericardial malignant mesothelioma treated with pemetrexed and cisplatin)

[SCI] (Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05))

[SCI] (Association between hand grip strength and impaired health-related quality of life in Korean cancer survivors: a cross-sectional study)

[SCI] (A Prognostic index to identify patients with intrahepatic cholangiocarcinoma who could benefit from gemcitabine plus cisplatin)

[SCI] (Can serum be used for analyzing the KRAS mutation status in patients with advanced colorectal cancer?)

[SCI] (The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress)

[SCI] (Prognostic value of axillary nodal ratio after neoadjuvant chemotherapy of doxorubicin/cyclophosphamide followed by docetaxel: a multicenter retrospective cohort study)

[SCI] (Incidence and predictors of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy in Korea)